Search - tctmd.com

Displaying 1 - 20 of 23

Sort: Relevancy | Date

Presentation ESC 2022

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Presenter: Valentin Fuster

August 29, 2022

Presentation Controversies and Advances 2019

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

Presenter: Tarun Chakravarty

November 15, 2019

Presentation JIM 2019

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Presenter: Maurice Buchbinder

February 14, 2019

Presentation EuroPCR 2018

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

Presenter: Hasan Jilaihawi

May 23, 2018

Presentation Scripps 2016

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

Presenter: Brian Whisenant

February 04, 2016

Presentation Scripps 2016

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

Presenter: Brian K. Whisenant

February 03, 2016

Presentation

LAA Occlusion for Stroke Prevention in A-Fib

Presenter: Apostolos Tzikas

January 29, 2015

Presentation

Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

Presenter: Ka Sing Lawrence Wong

April 29, 2014

Presentation

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Presenter: Paul Dorian

February 20, 2014

Presentation

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

Presenter: William A. Gray

December 02, 2013

Presentation TCT 2013

How the Cardiologist Can Help in Stroke Prevention

Presenter: Leo Nelson Hopkins

October 31, 2013

Presentation TCT 2013

Stroke Prevention During Cardioversion: Are TEEs Needed?

Presenter: Allan Klein

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Presenter: Saibal Kar

October 29, 2013

Presentation

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

Presenter: Yongjun Wang

June 26, 2013

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

Presentation TCT 2012

When Does Brachiocephalic and Vertebral Disease Warrant Intervention for Stroke Prevention, and What Are the Expected Outcomes?

Presenter: Tyrone Collins

October 24, 2012

Presentation TCT 2012

Atherosclerotic Carotid Bifurcation Stenosis: Primary and Secondary Prevention Strategies

Presenter: William Gray

October 24, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

New Oral Anticoagulants for Stroke Prevention

Presenter: Nicole R. Gonzales

May 02, 2012

Advertisement

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Stroke Prevention

LAA Occlusion In the Prevention of Stroke: Efficacy, Safety and Cost Benefit Is the Data Convincing?

Anatomical Predictors of Stroke Prevention During Transcatheter Aortic Valve Implantation: The SENTINEL Trial

LAA Closure for Prevention of AF Stroke: Clinical Trial Data

LAA Closure for Stroke Prevention: Novel and Next Generation Devices

LAA Occlusion for Stroke Prevention in A-Fib

Rivaroxaban for Stroke Prevention in East Asian Patients from the ROCKET AF Trial

Cost-Effectiveness of Apixaban vs Current Standard of Care for Stroke Prevention in A-fib Patients

Interventional Approaches to Stroke Prevention in Atrial Fibrillation

How the Cardiologist Can Help in Stroke Prevention

Stroke Prevention During Cardioversion: Are TEEs Needed?

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Clopidogrel with Aspirin in Acute Minor Stroke or TIA

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

When Does Brachiocephalic and Vertebral Disease Warrant Intervention for Stroke Prevention, and What Are the Expected Outcomes?

Atherosclerotic Carotid Bifurcation Stenosis: Primary and Secondary Prevention Strategies

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

New Oral Anticoagulants for Stroke Prevention

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content